Spire Healthcare Group PLC Director/PDMR Shareholding (1619B)

TIDMSPI

RNS Number : 1619B

Spire Healthcare Group PLC

31 March 2017

31 March 2017

Spire Healthcare Group plc (the "Company")

Exercise of 2014 Long Term Incentive Plan award

On 30 March 2017, Simon Gordon, an Executive Director of the Company, exercised his vested Long Term Incentive Plan award (the "Award") over ordinary shares in the Company. The Award was originally granted in the form of nil-cost options on 30 September 2014.

Performance conditions

The performance period for the Award ended on 31 December 2016. The Award was based on targets linked to earnings per share (EPS) and relative total shareholder return (TSR) performance.

Half of the Award was based on TSR performance measured against the constituents of the FTSE 250 (excluding investment trusts). Threshold vesting (25% of the element) required median performance, with outperformance of the upper quartile required for full vesting. Over the period to 31 December 2016, the Company delivered a total shareholder return of +76%. This was well within the upper quartile of the comparator group, and therefore this element of the Award vested in full.

The remaining half of the award was based on EPS targets. The 2016 EPS was below the threshold of 20.6 pence, and therefore this element of the Award lapsed in full.

Exercise of Award

Simon Gordon sold sufficient shares to cover his Income Tax and NIC liabilities and then retained the balance of his Award.

 
 Director        Type of award    Shares vested    Shares   Shareholding 
                                   and exercised    sold*     following 
                                                             transaction 
--------------  ---------------  ---------------  -------  ------------- 
                 Conditional 
                  Share Award 
                  (in the form 
                  of nil-cost 
 Simon Gordon     options)           124,113       58,539     537,332 
--------------  ---------------  ---------------  -------  ------------- 
 

*All shares sold were at an average share price of 327.5829 pence.

Enquiries:

Philip Davies

Deputy Company Secretary

020 7427 9092

The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

 
 1     Details of the person discharging managerial 
        responsibilities/person closely associated 
----  -------------------------------------------------------------------- 
 a)    Name                      Simon Gordon 
----  ------------------------  ------------------------------------------ 
 2     Reason for the notification 
----  -------------------------------------------------------------------- 
 a)    Position/status           Executive Director and Chief Financial 
                                  Officer 
----  ------------------------  ------------------------------------------ 
 b)    Initial notification      Initial notification 
        /Amendment 
----  ------------------------  ------------------------------------------ 
 3     Details of the issuer, emission allowance 
        market participant, auction platform, auctioneer 
        or auction monitor 
----  -------------------------------------------------------------------- 
 a)    Name                      Spire Healthcare Group plc 
----  ------------------------  ------------------------------------------ 
 b)    LEI                       n/a 
----  ------------------------  ------------------------------------------ 
 4     Details of the transaction(s): section to 
        be repeated for (i) each type of instrument; 
        (ii) each type of transaction; (iii) each 
        date; and (iv) each place where transactions 
        have been conducted 
----  -------------------------------------------------------------------- 
 a)    Description               Ordinary shares of 1 pence each 
        of the financial 
        instrument, 
        type of instrument 
        Identification 
        code 
----  ------------------------  ------------------------------------------ 
 b)    Nature of                 Exercise of a nil-cost share option 
        the transaction           over 124,113 shares granted under 
                                  the Company's Long Term Incentive 
                                  Plan and subsequent sale of 58,539 
                                  shares to cover Income Tax and 
                                  NIC liabilities. 
----  ------------------------  ------------------------------------------ 
 c)    Price(s) and                      Price(s)              Volume(s) 
        volume(s) 
----  ------------------------  --------------------------  -------------- 
                       327.5829 pence                           58,539 
  --------------------------------------------------------  -------------- 
 
 d)    Aggregated                As above 
        information 
        - Aggregated 
        volume 
        - Price 
----  ------------------------  ------------------------------------------ 
 e)    Date of the               2017-03-30 
        transaction 
----  ------------------------  ------------------------------------------ 
 f)    Place of the              XLON 
        transaction 
----  ------------------------  ------------------------------------------ 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHGIGDXGSXBGRB

(END) Dow Jones Newswires

March 31, 2017 04:40 ET (08:40 GMT)